Eligibility Coronary Artery Disease NCT01623193

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients (male and female) undergoing isolated coronary artery bypass grafting,
Description

ID.1

Data type

boolean

isolated aortic or mitral repair or replacement, and
Description

ID.2

Data type

boolean

combined aortic or mitral valve repair or replacement and
Description

ID.3

Data type

boolean

coronary bypass grafting
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
reoperation,
Description

ID.5

Data type

boolean

endocarditis,
Description

ID.6

Data type

boolean

dialysis dependant renal failure,
Description

ID.7

Data type

boolean

pre-operative ecmo or lvad support,
Description

ID.8

Data type

boolean

contraindication to blood transfusion (ie. jehovah's witness), and
Description

ID.9

Data type

boolean

use of irreversible anti-platelet (other than asa) and anticoagulant agents within 48h (ie. plavix, dabigitran, gpiib/iiia inhibitors, argatroban).
Description

ID.10

Data type

boolean

Similar models

Eligibility Coronary Artery Disease NCT01623193

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients (male and female) undergoing isolated coronary artery bypass grafting,
boolean
ID.2
Item
isolated aortic or mitral repair or replacement, and
boolean
ID.3
Item
combined aortic or mitral valve repair or replacement and
boolean
ID.4
Item
coronary bypass grafting
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
reoperation,
boolean
ID.6
Item
endocarditis,
boolean
ID.7
Item
dialysis dependant renal failure,
boolean
ID.8
Item
pre-operative ecmo or lvad support,
boolean
ID.9
Item
contraindication to blood transfusion (ie. jehovah's witness), and
boolean
ID.10
Item
use of irreversible anti-platelet (other than asa) and anticoagulant agents within 48h (ie. plavix, dabigitran, gpiib/iiia inhibitors, argatroban).
boolean